Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Gastroenterology & Hepatology|April 23, 2019
A randomized double-blinded sham-controlled cross-over trial of tined-lead sacral nerve stimulation testing for chronic constipationYan Yiannakou, Kevin Etherson, Helen Close, et al.
Trials|January 29, 2017
Manubrium-limited ministernotomy versus conventional sternotomy for aortic valve replacement (MAVRIC): study protocol for a randomised controlled trialEnoch Akowuah, Andrew T Goodwin, W Andrew Owens, et al.
BMJ Open|January 8, 2025
Trial of alginates in throat symptoms: protocol for a pragmatic, multicentre, placebo controlled, double blind, parallel, randomised controlled trial of liquid alginate (Gaviscon Advance) for the treatment of persistent throat symptomsMiranda Morton, Hesther Smith, Tony Fouweather, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|May 5, 2024
Antithrombotic therapy after heart valve surgery: contemporary practice in the UKNabila Laskar, Christopher D Bayliss, Bilal H Kirmani, et al.
Geroscience|April 22, 2023
Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarctionBilal Bawamia, Luke Spray, Vincent K Wangsaputra, et al.
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
Gut|May 20, 2016
Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) studyColin J Rees, Praveen T Rajasekhar, Ana Wilson, et al.
BMJ Open|December 25, 2025
Surgery versus conservative management for severe pectus excavatum (RESTORE): protocol for a multicentre, randomised, controlled superiority trialRebecca Maier, Joel Dunning, James Wason, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
BMC Medicine|August 9, 2022
Practical guidance for planning resources required to support publicly-funded adaptive clinical trialsJames M S Wason, Munyaradzi Dimairo, Katie Biggs, et al.
Pageof 3